Medical Company Receives New Patent For COVID-19 Drug

RedHill Biopharma's New Patent: A Potential Game-Changer in the Fight Against Coronavirus.

This article is intended for informational purposes only and should not be considered as medical advice. Always consult with a healthcare professional for medical advice.

In a significant development in the medical community, RedHill Biopharma Ltd ($RDHL) has been granted US patent number 11,918,560, titled "Serine Protease Inhibitor for Treating Coronav…